Arterex

Founded in 2022, Arterex (“the Group”) is a multi-capability medical device contract manufacturing platform combining the operations of NextPhase, Formula Plastics, Micromold, Kabo, Luc & Bel, and Modenplast.

The Group produces Class I, II and III medical devices and serves a wide range of customers, from leading global medical and healthcare OEMs (e.g., Fresenius, B. Braun) to smaller regional specialty customers primarily in Europe and the US.

The Group has a global manufacturing footprint with 8 state-of-the-art facilities across North America, Europe, and North Africa, totaling approximately approximately 544,000 square feet of manufacturing and warehousing space with approximately 1,100 employees.